CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

(2018) Christian Barro et al.   BRAIN

CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?

(2018) Peter Körtvelyessy et al.   Frontiers in Neurology

Fluid biomarker and electrophysiological outcome measures for progressive MS trials

(2017) Christian Barro et al.   Multiple Sclerosis Journal

Peripheral nerve atrophy together with higher cerebrospinal fluid progranulin indicate axonal damage in amyotrophic lateral sclerosis

(2017) Stefanie Schreiber et al.   MUSCLE & NERVE

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

(2017) Xavier Montalban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis

(2017) Alessandra Gaiani et al.   JAMA Neurology

Fluid biomarker and electrophysiological outcome measures for progressive MS trials

(2017) Christian Barro et al.   Multiple Sclerosis Journal

Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis

(2016) M.Alba Mañé-Martínez et al.   JOURNAL OF NEUROIMMUNOLOGY

A clinical tool for predicting survival in ALS

(2016) Jonathan A Knibb et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Progranulin levels in status epilepticus as a marker of neuronal recovery and neuroprotection

(2015) T. Huchtemann et al.   EPILEPSY & BEHAVIOR

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?

(2015) Ahmed Abdelhak et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

(2015) Petra Steinacker et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis

(2015) S Modvig et al.   Multiple Sclerosis Journal

Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis

(2015) S Modvig et al.   Multiple Sclerosis Journal

N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis

(2014) Alessandro Trentini et al.   JOURNAL OF NEUROLOGY

The natural history of early versus late disability accumulation in primary progressive MS

(2014) Marcus W Koch et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome

(2014) J. Kuhle et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis

(2013) Markus Axelsson et al.   Multiple Sclerosis Journal

A comparative study of CSF neurofilament light and heavy chain protein in MS

(2013) Jens Kuhle et al.   Multiple Sclerosis Journal

Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis

(2012) Roberto Madeddu et al.   NEUROLOGICAL SCIENCES

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Neurofilament light as a prognostic marker in multiple sclerosis

(2010) Jonatan Salzer et al.   Multiple Sclerosis Journal

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

(2009) C. E. Teunissen et al.   NEUROLOGY

Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology

(2008) Axel Petzold et al.   EXPERIMENTAL NEUROLOGY